Literature DB >> 15152143

Effect of completeness of revascularization on clinical outcome in patients with multivessel disease presenting with unstable angina who undergo percutaneous coronary intervention.

N D Palmer1, J P Causer, D R Ramsdale, R A Perry.   

Abstract

We evaluated the current short- and medium-term outcomes of complete revascularization, compared to culprit lesion percutaneous coronary intervention (PCI), in patients with multivessel coronary disease presenting with unstable angina. One hundred fifty-one patients with multivessel coronary disease presented to a tertiary cardiothoracic center with unstable angina/non-ST elevation myocardial infarction (UA/NSTEMI) between January 2000 and September 2001. In group A (n=71), the intended strategy was complete revascularization by multivessel PCI. In group B (n=80), culprit lesion PCI was intended despite the presence of other lesions amenable to PCI (B1) or due to confounding anatomical factors (B2). Clinical variables and endpoints were collected from patient notes, a dedicated database and telephone follow-up, and included recurrent stable and unstable angina, need for repeat PCI or elective coronary artery bypass graft, incidence of non-fatal myocardial infarction (MI) and death. Baseline characteristics were similar in each group. Procedural success was achieved in over 95% of cases in both groups with high stent implantation rates (>96%). There was no observed difference in mortality or incidence of MI between the groups. Compared to group A, more patients in group B1 had residual angina [22.8% (13/57) versus 9.9% (7/71); p=0.041] and required further PCI [17.5% (10/57) versus 7.0% (5/71); p=0.045]. There was a non-significant trend toward fewer readmissions for UA and less long-term antianginal medication in group A [38.0% (27/71) versus 52.6% (30/57); p=0.043]. Complete and culprit lesion revascularization by PCI are safe methods of treating patients with multivessel coronary disease presenting with UA/NSTEMI. Reductions in residual angina, repeat PCI and need for antianginal therapies suggest that complete revascularization should be the strategy of choice when possible.

Entities:  

Mesh:

Year:  2004        PMID: 15152143

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  5 in total

1.  Complete and incomplete revascularization in non-ST segment myocardial infarction with multivessel disease: long-term outcomes of first- and second-generation drug-eluting stents.

Authors:  Ming-Jer Hsieh; Chun-Chi Chen; Cheng-Hung Lee; Chao-Yung Wang; Shang-Hung Chang; Dong-Yi Chen; Chia-Hung Yang; Ming-Lung Tsai; Jih-Kai Yeh; Ming-Yun Ho; I-Chang Hsieh
Journal:  Heart Vessels       Date:  2018-08-29       Impact factor: 2.037

Review 2.  Optimal Timing of Complete Revascularization in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Rouan Gaffar; Bettina Habib; Kristian B Filion; Pauline Reynier; Mark J Eisenberg
Journal:  J Am Heart Assoc       Date:  2017-04-10       Impact factor: 5.501

3.  The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX.

Authors:  Celina M Yong; Vandana Sundaram; Freddy Abnousi; Christoph B Olivier; Jaden Yang; Gregg W Stone; Philippe G Steg; C Michael Gibson; Christian W Hamm; Matthew J Price; Efthymios N Deliargyris; Jayne Prats; Harvey D White; Robert A Harrington; Deepak L Bhatt; Kenneth W Mahaffey
Journal:  Clin Cardiol       Date:  2019-06-29       Impact factor: 2.882

Review 4.  Multivessel versus Single Vessel Angioplasty in Non-ST Elevation Acute Coronary Syndromes: A Systematic Review and Metaanalysis.

Authors:  Javier Mariani; Alejandro Macchia; Maximiliano De Abreu; Gabriel Gonzalez Villa Monte; Carlos Tajer
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

5.  Early and long-term outcomes of complete revascularization with percutaneous coronary intervention in patients with multivessel coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes.

Authors:  Michał Hawranek; Piotr Desperak; Paweł Gąsior; Aneta Desperak; Andrzej Lekston; Mariusz Gąsior
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-03-22       Impact factor: 1.426

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.